CME Group Inc. Logo

CME Group Inc.

CME

(2.5)
Stock Price

238,53 USD

3.56% ROA

12.51% ROE

24.11x PER

Market Cap.

79.825.637.920,00 USD

12.6% DER

4.42% Yield

56.79% NPM

CME Group Inc. Stock Analysis

CME Group Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

CME Group Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (12%), which means it has a small amount of debt compared to the ownership it holds

2 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

3 ROE

The stock's ROE falls within an average range (11.07%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (3.22%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 PBV

The stock's PBV ratio (2.72x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

6 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

7 Net Profit Growth

This company's net profit has been consistently on the rise over the past three years, indicating a strong financial performance and making it an appealing investment opportunity.

8 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (408), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

9 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

CME Group Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

CME Group Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

CME Group Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

CME Group Inc. Revenue
Year Revenue Growth
2000 226.552.000
2001 396.630.000 42.88%
2002 469.079.000 15.44%
2003 536.041.000 12.49%
2004 752.802.000 28.79%
2005 977.296.000 22.97%
2006 1.089.947.000 10.34%
2007 1.756.101.000 37.93%
2008 2.561.019.000 31.43%
2009 2.612.800.000 1.98%
2010 3.003.700.000 13.01%
2011 3.280.600.000 8.44%
2012 2.914.600.000 -12.56%
2013 2.936.300.000 0.74%
2014 3.112.500.000 5.66%
2015 3.326.800.000 6.44%
2016 3.595.200.000 7.47%
2017 3.644.700.000 1.36%
2018 4.309.400.000 15.42%
2019 4.868.000.000 11.47%
2020 4.883.600.000 0.32%
2021 4.689.700.000 -4.13%
2022 5.019.400.000 6.57%
2023 5.351.200.000 6.2%
2023 5.578.900.000 4.08%
2024 6.130.000.000 8.99%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

CME Group Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 97.600.000 100%
2017 101.600.000 3.94%
2018 117.200.000 13.31%
2019 201.500.000 41.84%
2020 198.500.000 -1.51%
2021 192.600.000 -3.06%
2022 188.600.000 -2.12%
2023 0 0%
2023 218.700.000 100%
2024 256.399.996 14.7%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

CME Group Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2000 0
2001 200.079.000 100%
2002 204.342.000 2.09%
2003 230.317.000 11.28%
2004 261.280.000 11.85%
2005 279.336.000 6.46%
2006 79.507.000 -251.34%
2007 136.995.000 41.96%
2008 71.944.000 -90.42%
2009 165.500.000 56.53%
2010 157.500.000 -5.08%
2011 162.400.000 3.02%
2012 337.100.000 51.82%
2013 360.100.000 6.39%
2014 398.200.000 9.57%
2015 403.600.000 1.34%
2016 437.700.000 7.79%
2017 421.400.000 -3.87%
2018 453.900.000 7.16%
2019 174.100.000 -160.71%
2020 191.300.000 8.99%
2021 151.700.000 -26.1%
2022 137.400.000 -10.41%
2023 128.800.000 -6.68%
2023 144.400.000 10.8%
2024 138.800.000 -4.03%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

CME Group Inc. EBITDA
Year EBITDA Growth
2000 25.406.000
2001 123.842.000 79.49%
2002 176.371.000 29.78%
2003 206.125.000 14.43%
2004 386.669.000 46.69%
2005 565.157.000 31.58%
2006 693.638.000 18.52%
2007 1.156.146.000 40%
2008 1.719.536.000 32.76%
2009 1.715.400.000 -0.24%
2010 1.961.000.000 12.52%
2011 2.149.600.000 8.77%
2012 1.828.900.000 -17.54%
2013 1.772.100.000 -3.21%
2014 1.901.000.000 6.78%
2015 2.117.900.000 10.24%
2016 2.331.900.000 9.18%
2017 2.425.000.000 3.84%
2018 2.726.300.000 11.05%
2019 2.746.400.000 0.73%
2020 2.790.600.000 1.58%
2021 2.793.000.000 0.09%
2022 3.150.800.000 11.36%
2023 -681.200.000 562.54%
2023 3.788.300.000 117.98%
2024 4.339.200.000 12.7%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

CME Group Inc. Gross Profit
Year Gross Profit Growth
2000 226.552.000
2001 361.560.000 37.34%
2002 429.222.000 15.76%
2003 489.458.000 12.31%
2004 701.357.000 30.21%
2005 909.410.000 22.88%
2006 789.885.000 -15.13%
2007 1.398.803.000 43.53%
2008 2.131.515.000 34.38%
2009 2.083.500.000 -2.3%
2010 2.363.000.000 11.83%
2011 2.584.400.000 8.57%
2012 2.377.800.000 -8.69%
2013 2.382.100.000 0.18%
2014 2.528.400.000 5.79%
2015 2.745.300.000 7.9%
2016 3.027.400.000 9.32%
2017 3.057.900.000 1%
2018 3.637.200.000 15.93%
2019 3.969.300.000 8.37%
2020 4.027.100.000 1.44%
2021 3.852.700.000 -4.53%
2022 4.266.300.000 9.69%
2023 4.529.200.000 5.8%
2023 4.540.400.000 0.25%
2024 5.054.400.000 10.17%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

CME Group Inc. Net Profit
Year Net Profit Growth
2000 -5.909.000
2001 68.302.000 108.65%
2002 94.067.000 27.39%
2003 122.132.000 22.98%
2004 219.555.000 44.37%
2005 306.857.000 28.45%
2006 407.348.000 24.67%
2007 658.533.000 38.14%
2008 715.486.000 7.96%
2009 825.800.000 13.36%
2010 951.400.000 13.2%
2011 1.812.300.000 47.5%
2012 896.300.000 -102.2%
2013 976.800.000 8.24%
2014 1.127.100.000 13.34%
2015 1.247.000.000 9.62%
2016 1.534.100.000 18.71%
2017 4.063.400.000 62.25%
2018 1.962.200.000 -107.08%
2019 2.116.500.000 7.29%
2020 2.105.200.000 -0.54%
2021 2.636.400.000 20.15%
2022 2.691.000.000 2.03%
2023 3.000.800.000 10.32%
2023 3.226.200.000 6.99%
2024 3.532.800.000 8.68%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

CME Group Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2000 0
2001 0 0%
2002 1 0%
2003 1 0%
2004 1 100%
2005 2 0%
2006 2 50%
2007 3 33.33%
2008 2 -50%
2009 2 0%
2010 3 0%
2011 5 60%
2012 3 -150%
2013 3 0%
2014 3 33.33%
2015 4 0%
2016 5 25%
2017 12 66.67%
2018 6 -140%
2019 6 0%
2020 6 0%
2021 7 28.57%
2022 7 0%
2023 8 12.5%
2023 9 0%
2024 10 11.11%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

CME Group Inc. Free Cashflow
Year Free Cashflow Growth
2000 21.799.000
2001 104.267.000 79.09%
2002 84.797.000 -22.96%
2003 128.133.000 33.82%
2004 261.310.000 50.97%
2005 305.966.000 14.6%
2006 383.886.000 20.3%
2007 650.730.000 41.01%
2008 997.095.000 34.74%
2009 925.200.000 -7.77%
2010 1.196.400.000 22.67%
2011 1.174.100.000 -1.9%
2012 1.075.000.000 -9.22%
2013 1.154.900.000 6.92%
2014 1.150.700.000 -0.36%
2015 1.401.100.000 17.87%
2016 1.624.200.000 13.74%
2017 1.758.500.000 7.64%
2018 2.324.100.000 24.34%
2019 2.427.200.000 4.25%
2020 2.518.100.000 3.61%
2021 2.275.200.000 -10.68%
2022 2.966.300.000 23.3%
2023 3.377.400.000 12.17%
2023 750.200.000 -350.2%
2024 758.700.000 1.12%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

CME Group Inc. Operating Cashflow
Year Operating Cashflow Growth
2000 32.969.000
2001 120.569.000 72.66%
2002 141.138.000 14.57%
2003 191.149.000 26.16%
2004 328.806.000 41.87%
2005 391.593.000 16.03%
2006 471.696.000 16.98%
2007 814.374.000 42.08%
2008 1.197.197.000 31.98%
2009 1.083.100.000 -10.53%
2010 1.356.400.000 20.15%
2011 1.346.300.000 -0.75%
2012 1.216.800.000 -10.64%
2013 1.280.500.000 4.97%
2014 1.291.400.000 0.84%
2015 1.515.300.000 14.78%
2016 1.716.000.000 11.7%
2017 1.840.400.000 6.76%
2018 2.440.800.000 24.6%
2019 2.672.800.000 8.68%
2020 2.715.600.000 1.58%
2021 2.402.400.000 -13.04%
2022 3.056.000.000 21.39%
2023 3.453.800.000 11.52%
2023 750.200.000 -360.38%
2024 776.900.000 3.44%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

CME Group Inc. Capital Expenditure
Year Capital Expenditure Growth
2000 11.170.000
2001 16.302.000 31.48%
2002 56.341.000 71.07%
2003 63.016.000 10.59%
2004 67.496.000 6.64%
2005 85.627.000 21.17%
2006 87.810.000 2.49%
2007 163.644.000 46.34%
2008 200.102.000 18.22%
2009 157.900.000 -26.73%
2010 160.000.000 1.31%
2011 172.200.000 7.08%
2012 141.800.000 -21.44%
2013 125.600.000 -12.9%
2014 140.700.000 10.73%
2015 114.200.000 -23.2%
2016 91.800.000 -24.4%
2017 81.900.000 -12.09%
2018 116.700.000 29.82%
2019 245.600.000 52.48%
2020 197.500.000 -24.35%
2021 127.200.000 -55.27%
2022 89.700.000 -41.81%
2023 76.400.000 -17.41%
2023 0 0%
2024 18.200.000 100%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

CME Group Inc. Equity
Year Equity Growth
2000 163.671.000
2001 250.369.000 34.63%
2002 446.139.000 43.88%
2003 562.995.000 20.76%
2004 812.597.000 30.72%
2005 1.118.684.000 27.36%
2006 1.519.092.000 26.36%
2007 12.305.637.000 87.66%
2008 18.688.569.000 34.15%
2009 19.301.000.000 3.17%
2010 20.127.000.000 4.1%
2011 21.622.300.000 6.92%
2012 21.505.700.000 -0.54%
2013 21.160.500.000 -1.63%
2014 20.923.500.000 -1.13%
2015 20.551.800.000 -1.81%
2016 20.590.000.000 0.19%
2017 22.651.200.000 9.1%
2018 25.965.300.000 12.76%
2019 26.159.300.000 0.74%
2020 26.351.500.000 0.73%
2021 28.470.200.000 7.44%
2022 28.005.500.000 -1.66%
2023 27.592.900.000 -1.5%
2023 28.151.600.000 1.98%
2024 27.635.800.000 -1.87%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

CME Group Inc. Assets
Year Assets Growth
2000 381.444.000
2001 2.068.881.000 81.56%
2002 3.355.016.000 38.33%
2003 4.872.636.000 31.15%
2004 2.857.466.000 -70.52%
2005 3.969.394.000 28.01%
2006 4.306.505.000 7.83%
2007 20.306.197.000 78.79%
2008 48.158.654.000 57.83%
2009 35.651.000.000 -35.08%
2010 35.044.900.000 -1.73%
2011 40.758.700.000 14.02%
2012 38.863.200.000 -4.88%
2013 54.277.800.000 28.4%
2014 72.241.500.000 24.87%
2015 67.371.500.000 -7.23%
2016 69.369.400.000 2.88%
2017 75.791.200.000 8.47%
2018 77.475.700.000 2.17%
2019 75.215.300.000 -3.01%
2020 124.659.600.000 39.66%
2021 196.780.300.000 36.65%
2022 174.175.700.000 -12.98%
2023 129.840.500.000 -34.15%
2023 125.598.200.000 -3.38%
2024 123.379.300.000 -1.8%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

CME Group Inc. Liabilities
Year Liabilities Growth
2000 217.773.000
2001 1.818.512.000 88.02%
2002 2.908.877.000 37.48%
2003 4.309.641.000 32.5%
2004 2.044.869.000 -110.75%
2005 2.850.710.000 28.27%
2006 2.787.413.000 -2.27%
2007 8.000.560.000 65.16%
2008 29.470.085.000 72.85%
2009 16.350.000.000 -80.25%
2010 14.917.900.000 -9.6%
2011 19.136.400.000 22.04%
2012 17.357.500.000 -10.25%
2013 33.117.300.000 47.59%
2014 51.318.000.000 35.47%
2015 46.819.700.000 -9.61%
2016 49.028.700.000 4.51%
2017 53.379.400.000 8.15%
2018 51.510.400.000 -3.63%
2019 49.056.000.000 -5%
2020 98.308.100.000 50.1%
2021 169.381.000.000 41.96%
2022 147.297.000.000 -14.99%
2023 103.102.600.000 -42.86%
2023 97.446.600.000 -5.8%
2024 95.743.500.000 -1.78%

CME Group Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
16.13
Net Income per Share
9.19
Price to Earning Ratio
24.11x
Price To Sales Ratio
13.77x
POCF Ratio
22.31
PFCF Ratio
22.86
Price to Book Ratio
2.88
EV to Sales
14.12
EV Over EBITDA
28.15
EV to Operating CashFlow
22.93
EV to FreeCashFlow
23.45
Earnings Yield
0.04
FreeCashFlow Yield
0.04
Market Cap
79,83 Bil.
Enterprise Value
81,88 Bil.
Graham Number
126.13
Graham NetNet
-259.86

Income Statement Metrics

Net Income per Share
9.19
Income Quality
1.08
ROE
0.12
Return On Assets
0.02
Return On Capital Employed
0.1
Net Income per EBT
0.77
EBT Per Ebit
1.16
Ebit per Revenue
0.64
Effective Tax Rate
0.22

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.83
Operating Profit Margin
0.64
Pretax Profit Margin
0.74
Net Profit Margin
0.57

Dividends

Dividend Yield
0.04
Dividend Yield %
4.42
Payout Ratio
1.07
Dividend Per Share
9.8

Operating Metrics

Operating Cashflow per Share
9.94
Free CashFlow per Share
9.72
Capex to Operating CashFlow
0.02
Capex to Revenue
0.01
Capex to Depreciation
0.23
Return on Invested Capital
0.09
Return on Tangible Assets
0.04
Days Sales Outstanding
37.74
Days Payables Outstanding
36.41
Days of Inventory on Hand
0
Receivables Turnover
9.67
Payables Turnover
10.02
Inventory Turnover
0
Capex per Share
0.22

Balance Sheet

Cash per Share
5,33
Book Value per Share
76,91
Tangible Book Value per Share
-8.24
Shareholders Equity per Share
76.91
Interest Debt per Share
10.13
Debt to Equity
0.13
Debt to Assets
0.03
Net Debt to EBITDA
0.71
Current Ratio
1.02
Tangible Asset Value
-2,96 Bil.
Net Current Asset Value
-6,99 Bil.
Invested Capital
33005200000
Working Capital
1,77 Bil.
Intangibles to Total Assets
0.25
Average Receivables
0,61 Bil.
Average Payables
0,11 Bil.
Average Inventory
0
Debt to Market Cap
0.04

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

CME Group Inc. Dividends
Year Dividends Growth
2003 1
2004 1 100%
2005 2 0%
2006 3 50%
2007 3 33.33%
2008 10 66.67%
2009 5 -125%
2010 5 0%
2011 6 20%
2012 10 44.44%
2013 4 -125%
2014 4 -33.33%
2015 5 25%
2016 6 20%
2017 6 16.67%
2018 5 -50%
2019 6 20%
2020 6 0%
2021 7 16.67%
2022 9 25%
2023 10 11.11%
2024 3 -200%

CME Group Inc. Profile

About CME Group Inc.

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

CEO
Mr. Terrence A. Duffy
Employee
3.565
Address
20 South Wacker Drive
Chicago, 60606

CME Group Inc. Executives & BODs

CME Group Inc. Executives & BODs
# Name Age
1 Mr. Terrence A. Duffy
Chairman & Chief Executive Officer
70
2 Mr. Michael G. Dennis
Global Head of Fixed Income
70
3 Mr. John C. Peschier
Managing Director of Investor Relations
70
4 Mr. Jonathan L. Marcus J.D.
Senior MD & General Counsel
70
5 Ms. Lynne Fitzpatrick
President & Chief Financial Officer
70
6 Ms. Suzanne Sprague
Senior MD, Chief Operating Officer & Global Head of Clearing
70
7 Mr. Jack Tobin
MD & Chief Accounting Officer
70
8 Ms. Anita Liskey
Senior Managing Director of Corporate Marketing & Communications
70
9 Mr. Sunil Cutinho
Chief Information Officer
70
10 Mr. Derek Sammann
Senior MD & Global Head of Commodities Markets
70

CME Group Inc. Competitors

Nasdaq, Inc. Logo
Nasdaq, Inc.

NDAQ

(2.0)
S&P Global Inc. Logo
S&P Global Inc.

SPGI

(3.0)
MSCI Inc. Logo
MSCI Inc.

MSCI

(3.8)
Morningstar, Inc. Logo
Morningstar, Inc.

MORN

(2.2)